YouHodler Lists ApeCoin (APE) With Limited-Time 30% Interest Rate
LAUSANNE, SWITZERLAND, Apr 5, 2022 – (ACN Newswire) – Swiss financial intermediary and FinTech platform…
LAUSANNE, SWITZERLAND, Apr 5, 2022 – (ACN Newswire) – Swiss financial intermediary and FinTech platform…
CEO Joe Walsh calls 2020s “The Decade of Small Business Automation” and says local firms…
One in three pets gets lost during their lifetime. AskVet streamlines the search and rescue…
Potter Joined Actian as Chief Revenue Officer in 2019 to drive global revenue operations PALO…
Voice and Cloud Call Center solution provider to expand its partnership with ServiceNow to deliver…
DALLAS & MONTREAL–(BUSINESS WIRE)–#aerospace—Jaunt Air Mobility (“Jaunt”) announced that Calin Rovinescu, Air Canada’s recently retired…
New partnership to provide Liga MX’s Necaxa with cutting-edge tracking, analysis and video augmentation tools…
Travel time per light rail vehicle was reduced by 66 seconds resulting in a travel…
Thales strengthens its status as a cybersecurity leader with the creation of a new Security…
Munich (DE), Nice (FR), April 5, 2022 Hypertrust Patient Data Care (HPDC) today announced the…
New research from Managed Business IT Services provider (M-BiTS) TDM Group shows that 29% of…
Speedcast portfolio addition offers certified safety communications services for maritime customers Aberdeen, United Kingdom —…
Network detections in EMEA quadrupled, with malware detections occurring at nearly twice the rate as…
A recent UK partners survey conducted by Nuvias points to continued growth in 2022 whilst…
Medesis Pharma wishes to accelerate the development of its antinuclear products and provides an update…
Phase 1a dose escalation of ART0380 defined initial regimen to be evaluated in Phase 1b…
Clearance of critical milestone expands capability for production of gene therapies, starting with Zolgensma® Basel,…
Figure 1 Kaplan Meier – Preliminary survival rate analysis of Roll-In Cohort, dated 25 March…
ST. LOUIS, April 05, 2022 (GLOBE NEWSWIRE) — Curium announced today that its generic version…
Interim data suggest long-term treatment with VYVGART provides improvement in generalized myasthenia gravis (gMG)…